NCT02472392View on ClinicalTrials.gov

Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
EWINGS SARCOMA
Interventions
DRUG

Rabbit anti-thymocyte globulin

Active treatment

DRUG

Busulfan

comparitor

DRUG

Melphalan

comparitor

DRUG

Fludarabine

comparitor

DRUG

Cyclophosphamide

comparitor

Trial Locations (1)

40202

University of Louisville, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT02472392 - Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma | Biotech Hunter | Biotech Hunter